Although most genetic and molecular alterations have been identified, characterization of all interactions between key effectors in MAPK, CDKN2A, and additional (i.e. PTEN-AKT) pathways will represent the aims of future research efforts, in order to further clarify the sequence of events inducing transformation of melanocytes and progression of melanoma. This evidence concerns the gene PTEN and melanoma.